Trento, Italy

Assunta Gagliardi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biomvis Srl. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Assunta Gagliardi. Retrieved from https://idiyas.com/inventor/assunta-gagliardi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Assunta Gagliardi: Innovator in Immunogenic Compositions

Introduction

Assunta Gagliardi is a notable inventor based in Trento, Italy. She has made significant contributions to the field of immunology through her innovative research and development.

Latest Patents

Assunta Gagliardi holds a patent titled "Method for the Production of Outer Membrane Vesicles and Immunogenic Compositions Thereof." This patent reflects her expertise in creating immunogenic compositions that can have a profound impact on vaccine development.

Career Highlights

Gagliardi is associated with Biomvis Srl, a company that focuses on biotechnological advancements. Her work at Biomvis Srl has positioned her as a key player in the field of immunology.

Collaborations

Throughout her career, Assunta Gagliardi has collaborated with esteemed colleagues such as Guido Grandi and Laura Fantappie. These collaborations have further enhanced her research and contributions to the scientific community.

Conclusion

Assunta Gagliardi's innovative work in immunogenic compositions showcases her dedication to advancing medical science. Her contributions are vital for the future of vaccine development and immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…